Canton Strategic Holdings Inc (NASDAQ: CNTN) is a Healthcare company (Biotechnology) with a market capitalization of $113M. The Maz Rating grades it against the other companies in its sector.
Canton Strategic Holdings Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $1.42, Canton Strategic Holdings Inc trades at 24.4x sales and 0.7x book value. Over the last twelve months it generated about $5M of revenue and a net loss of $113M. It runs a gross margin of 32.9%, an operating margin of -1129.2% and a net margin of -2883.0%. It shows return on equity of -30.1%, return on invested capital of -7.8% and a free cash flow yield of -20.1%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 19.05. Over the past 52 weeks the share price ranged from $1.38 to $5.83, with a beta of 1.51.
Canton Strategic Holdings Inc does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.